Buruli ulcer

Dr Edwin Ampadu

Nationality: Ghanaian

E-mail: ghanbu@4u.com.gh

Present position

  • Manager, National Buruli Ulcer Control Programme, Ministry of Health, Ghana

Areas of expertise/interest

  • Communicable disease control and surveillance
  • Organization of health service delivery
  • Programme planning, monitoring and evaluation
  • Capacity development
  • Operational research

Recent publications

  • Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, Phillips R, Evans M, Ofori-Adjei D, Klustse E, Owusu-Boateng J, Amedofu GK, Awuah P, Ampadu EO, Amofah G, Asiedu K, Wansbrough-Jones M. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother. 2005 Aug;49(8):3182-6. [Abstract/Free full text]
  • Stienstra Y, Dijkstra PU, Van Wezel MJ, Van Roest MH, Beets M, Zijlstra I, Johnson RC, Ampadu EO, Gbovi J, Zinsou C, Etuaful S, Klutse EY, Van der Graaf WT, Van der Werf TS. Reliability and validity of the Buruli ulcer functional limitation score questionnaire. Am J Trop Med Hyg. 2005 Apr;72(4):449-52. [Abstract/Free full text]
  • Hospers IC, Wiersma IC, Dijkstra PU, Stienstra Y, Etuaful S, Ampadu EO, van der Graaf WT, van der Werf TS. Distribution of Buruli ulcer lesions over body surface area in a large case series in Ghana: uncovering clues for mode of transmission. Trans R Soc Trop Med Hyg. 2005 Mar;99(3):196-201. [Abstract/Free full text]
  • Sarfo FS, Phillips RO, Ampadu EO, Sarpong F, Adentwe E, Wansbrough-Jones M. Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans. Clin Vaccine Immunol. 2009 Jan;16(1):61-5. Epub 2008 Nov 12. [Abstract/Free full text]
  • Williamson HR, Benbow ME, Nguyen KD, Beachboard DC, Kimbirauskas RK, McIntosh MD, Quaye C, Ampadu EO, Boakye D, Merritt RW, Small PL. Distribution of Mycobacterium ulcerans in Buruli Ulcer Endemic and Non-Endemic Aquatic Sites in Ghana. PLoS Negl Trop Dis. 2008 Mar 26;2(3):e205. [Abstract/Free full text]
  • Chukwuekezie O, Ampadu EO, Sopoh G, Dossou A, Tiendrebeogo A, Sadiq L, Portaels F, Asiedu K. Buruli ulcer, Nigeria. Emerg Infect Dis. 2007 May;13(5):782-3. [Abstract/Free full text]
  • Bretzel G, Siegmund V, Nitschke J, Herbinger KH, Thompson W, Klutse E, Crofts K, Massavon W, Etuaful S, Thompson R, Asamoah-Opare K, Racz P, Vloten F, van Berberich C, Kruppa T, Ampadu EO, Fleischer B, Adjei O. A stepwise approach to the laboratory diagnosis of Buruli ulcer disease. [Abstract/Free full text]
  • Kwyer TA, Ampadu EO. Buruli ulcers: an emerging health problem in Ghana. Adv Skin Wound Care. 2006 Nov-Dec;19(9):479-86.[Abstract/Free full text]
  • Stienstra Y, van der Werf TS, Oosterom E, Nolte IM, van der Graaf WT, Etuaful S, Raghunathan PL, Whitney EA, Ampadu EO, Asamoa K, Klutse EY, te Meerman GJ, Tappero JW, Ashford DA, van der Steege G. Susceptibility to Buruli ulcer is associated with the SLC11A1 (NRAMP1) D543N polymorphism. Genes Immun. 2006 Apr;7(3):185-9. [Abstract/Free full text]
  • Stienstra Y, van Roest MH, van Wezel MJ, Wiersma IC, Hospers IC, Dijkstra PU, Johnson RC, Ampadu EO, Gbovi J, Zinsou C, Etuaful S, Klutse EY, van der Graaf WT, van der Werf TS. Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients. Trop Med Int Health. 2005 Dec;10(12):1251-7. [Abstract/Free full text]
Share